Notably, HCC patients with agrin-positive tumors exhibited a lower recurrence-free survival rate compared to those with agrin-negative tumors (p = 0.001), highlighting the potential of agrin as a prognostic marker. Here, AGRN is linked to hepatocellular carcinoma.